]. A. Nahas, A. K. Bello-]-p, K. Boor, T. Sebekova, J. Ostendorf et al., Chronic kidney disease: the global challenge Treatment targets in renal fibrosis, Lancet Nephrol Dial Transplant, vol.3653, issue.22, pp.331-340, 2005.

F. Strutz, J. L. Bascands, J. P. Schanstra, M. Iwano, E. G. Neilson-]-d et al., Obstructive nephropathy: insights from genetically engineered animals Mechanisms of tubulointerstitial fibrosis The transforming growth factor beta system in kidney disease and repair: recent progress and future directions Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing, Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by plateletactivating-factor stimulation, pp.925-937, 1989.

M. Ruiz-ortega, R. Largo, C. Bustos, D. Gomez-garre, and J. Egido, Plateletactivating factor stimulates gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta, J Am Soc Nephrol, vol.8, pp.1266-1275, 1997.

K. Doi, K. Okamoto, K. Negishi, Y. Suzuki, A. Nakao et al., Attenuation of Folic Acid-Induced Renal Inflammatory Injury in Platelet-Activating Factor Receptor-Deficient Mice, The American Journal of Pathology, vol.168, issue.5, pp.1413-1424, 2006.
DOI : 10.2353/ajpath.2006.050634

S. N. Giri, A. K. Sharma, D. M. Hyde, and J. S. Wild, Amelioration of Bleomycin-Induced Lung Fibrosis by Treatment with the Platelet Activating Factor Receptor Antagonist Web 2086 in Hamsters, Experimental Lung Research, vol.96, issue.2, pp.287-307, 1995.
DOI : 10.1155/S096293519200005X

K. Kuroda, Y. Morimoto, A. Ogami, T. Oyabu, H. Nagatomo et al., Phospholipid Concentration in Lung Lavage Fluid as Biomarker for Pulmonary Fibrosis, Inhalation Toxicology, vol.89, issue.1, pp.389-393, 2006.
DOI : 10.1016/0041-008X(90)90109-8

K. Yasuda, A. Sato, K. Nishimura, K. Chida, and H. Hayakawa, Phospholipid analysis of alveolar macrophages and bronchoalveolar lavage fluid following bleomycin administration to rabbits, Lung, vol.172, issue.2, pp.91-102, 1994.
DOI : 10.1007/BF00185080

J. E. Adrian, K. Poelstra, G. L. Scherphof, D. K. Meijer, A. M. Van-loenen-weemaes et al., Effects of a New Bioactive Lipid-Based Drug Carrier on Cultured Hepatic Stellate Cells and Liver Fibrosis in Bile Duct-Ligated Rats, Journal of Pharmacology and Experimental Therapeutics, vol.321, issue.2, pp.536-543, 2007.
DOI : 10.1124/jpet.106.117945

B. Anliker and J. Chun, Cell surface receptors in lysophospholipid signaling, Seminars in Cell & Developmental Biology, vol.15, issue.5, pp.457-465, 2004.
DOI : 10.1016/j.semcdb.2004.05.005

H. Ohta, K. Sato, N. Murata, A. Damirin, E. Malchinkhuu et al., Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors, Molecular Pharmacology, vol.64, issue.4, pp.994-1005, 2003.
DOI : 10.1124/mol.64.4.994

A. Boucharaba, C. M. Serre, J. Guglielmi, J. C. Bordet, P. Clezardin et al., The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases, Proceedings of the National Academy of Sciences, vol.103, issue.25, pp.9643-9648, 2006.
DOI : 10.1073/pnas.0600979103

J. J. Contos, N. Fukushima, J. A. Weiner, D. Kaushal, and J. Chun, Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior, Proceedings of the National Academy of Sciences, vol.97, issue.24, pp.97-13384, 2000.
DOI : 10.1073/pnas.97.24.13384

J. J. Contos, I. Ishii, N. Fukushima, M. A. Kingsbury, X. Ye et al., Characterization of lpa2 (Edg4) and lpa1/lpa2 (Edg2/Edg4) Lysophosphatidic Acid Receptor Knockout Mice: Signaling Deficits without Obvious Phenotypic Abnormality Attributable to lpa2, Edg4) and lpaEdg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa, pp.6921-6929, 2002.
DOI : 10.1128/MCB.22.19.6921-6929.2002

X. Ye, K. Hama, J. J. Contos, B. Anliker, A. Inoue et al., LPA3-mediated lysophosphatidic acid signalling in embryo implantation and spacing, Nature, vol.14, issue.7038, pp.104-108, 2005.
DOI : 10.1074/jbc.M104441200

S. E. Gardell, A. E. Dubin, and J. Chun, Emerging medicinal roles for lysophospholipid signaling, Trends in Molecular Medicine, vol.12, issue.2, pp.65-75, 2006.
DOI : 10.1016/j.molmed.2005.12.001

C. Vial, L. M. Zuniga, C. Cabello-verrugio, P. Canon, R. Fadic et al., Skeletal muscle cells express the profibrotic cytokine connective tissue growth factor, which induces their dedifferentiation, 2007.

S. M. Chudgar, P. Deng, R. Maddala, D. L. Epstein, and P. V. Rao, Regulation of connective tissue growth factor expression in the aqueous humor outflow pathway, Mol Vis, vol.12, pp.1117-1126, 2006.

M. Eberlein, J. Heusinger-ribeiro, and M. Goppelt-struebe, Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins), British Journal of Pharmacology, vol.65, issue.7, pp.1172-1180, 2001.
DOI : 10.1038/sj.bjp.0704173

A. Graness, K. Giehl, and M. Goppelt-struebe, Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF), Cellular Signalling, vol.18, issue.4, pp.433-440, 2006.
DOI : 10.1016/j.cellsig.2005.05.011

A. Graness, V. Poli, and M. Goppelt-struebe, STAT3-independent inhibition of lysophosphatidic acid-mediated upregulation of connective tissue growth factor (CTGF) by cucurbitacin I, Biochemical Pharmacology, vol.72, issue.1, pp.72-104, 2006.
DOI : 10.1016/j.bcp.2006.04.001

A. Hahn, J. Heusinger-ribeiro, T. Lanz, S. Zenkel, and M. Goppelt-struebe, Induction of Connective Tissue Growth Factor by Activation of Heptahelical Receptors. MODULATION BY Rho PROTEINS AND THE ACTIN CYTOSKELETON, Journal of Biological Chemistry, vol.275, issue.48, pp.37429-37435, 2000.
DOI : 10.1074/jbc.M000976200

J. Heusinger-ribeiro, M. Eberlein, N. A. Wahab, and M. Goppelt-struebe, Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP, J Am Soc Nephrol, vol.12, pp.1853-1861, 2001.

S. Muehlich, N. Schneider, F. Hinkmann, C. D. Garlichs, and M. Goppelt-struebe, Induction of connective tissue growth factor (CTGF) in human endothelial cells by lysophosphatidic acid, sphingosine-1-phosphate, and platelets, Atherosclerosis, vol.175, issue.2, pp.261-268, 2004.
DOI : 10.1016/j.atherosclerosis.2004.04.011

J. P. Pradere, J. Klein, S. Gres, C. Guigne, E. Neau et al., LPA1 Receptor Activation Promotes Renal Interstitial Fibrosis, Journal of the American Society of Nephrology, vol.18, issue.12, pp.3110-3118, 2007.
DOI : 10.1681/ASN.2007020196

URL : https://hal.archives-ouvertes.fr/inserm-00409718

N. Wiedmaier, S. Muller, M. Koberle, B. Manncke, J. Krejci et al., Bacteria induce CTGF and CYR61 expression in epithelial cells in a lysophosphatidic acid receptor-dependent manner, International Journal of Medical Microbiology, vol.298, issue.3-4, 2007.
DOI : 10.1016/j.ijmm.2007.06.001

A. Leask and D. J. Abraham, TGF-?? signaling and the fibrotic response, The FASEB Journal, vol.18, issue.7, pp.816-827, 2004.
DOI : 10.1096/fj.03-1273rev

A. Kantarci, S. A. Black, C. E. Xydas, P. Murawel, Y. Uchida et al., Epithelial and connective tissue cell CTGF/CCN2 expression in gingival fibrosis, The Journal of Pathology, vol.287, issue.1, pp.210-59, 2006.
DOI : 10.1002/path.2000

H. Ikeda, Y. Yatomi, M. Yanase, H. Satoh, A. Nishihara et al., Effects of Lysophosphatidic Acid on Proliferation of Stellate Cells and Hepatocytes in Culture, Biochemical and Biophysical Research Communications, vol.248, issue.2, pp.436-440, 1998.
DOI : 10.1006/bbrc.1998.8983

J. Wu and M. A. Zern, Hepatic stellate cells: a target for the treatment of liver fibrosis, Journal of Gastroenterology, vol.35, issue.9, pp.665-672, 2000.
DOI : 10.1007/s005350070045

N. Watanabe, H. Ikeda, K. Nakamura, R. Ohkawa, Y. Kume et al., Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity, Life Sciences, vol.81, issue.12, pp.81-1009, 2007.
DOI : 10.1016/j.lfs.2007.08.013

H. Arai, M. Arai, K. Omata, Y. Fujiwara, and . Yatomi, Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C, J Clin Gastroenterol, vol.41, pp.616-623, 2007.

A. M. Tager, P. Lacamera, B. S. Shea, G. S. Campanella, M. Selman et al., The lysophosphatidic acid receptor LPA(1) links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak, Nat Med, 2007.

B. De-vries, R. A. Matthijsen, A. A. Van-bijnen, T. G. Wolfs, and W. A. Buurman, Lysophosphatidic Acid Prevents Renal Ischemia-Reperfusion Injury by Inhibition of Apoptosis and Complement Activation, The American Journal of Pathology, vol.163, issue.1, pp.47-56, 2003.
DOI : 10.1016/S0002-9440(10)63629-2

M. D. Okusa, H. Ye, L. Huang, L. Sigismund, T. Macdonald et al., receptors reduces murine renal ischemia-reperfusion injury, American Journal of Physiology - Renal Physiology, vol.285, issue.3, pp.565-574, 2003.
DOI : 10.1152/ajprenal.00023.2003

T. Sasagawa, K. Suzuki, T. Shiota, T. Kondo, and M. Okita, The Significance of Plasma Lysophospholipids in Patients with Renal Failure on Hemodialysis., Journal of Nutritional Science and Vitaminology, vol.44, issue.6, pp.44-809, 1998.
DOI : 10.3177/jnsv.44.809

R. N. Akalaev and A. A. , Abidov, [Phospholipid composition of erythrocytes in patients with chronic kidney failure], Vopr Med Khim, vol.39, pp.43-45, 1993.

V. S. Kamanna, B. V. Bassa, S. H. Ganji, and D. D. Roh, Bioactive lysophospholipids and mesangial cell intracellular signaling pathways: role in the pathobiology of kidney disease, Histol Histopathol, vol.20, pp.603-613, 2005.

J. S. Levine, J. S. Koh, V. Triaca, and W. , Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells, Am J Physiol, vol.273, pp.575-585, 1997.

F. Gaits, J. P. Salles, and H. Chap, Dual effect of lysophosphatidic acid on proliferation of glomerular mesangial cells, Kidney International, vol.51, issue.4, pp.1022-1027, 1997.
DOI : 10.1038/ki.1997.143

C. N. Inoue, H. G. Forster, and M. Epstein, Effects of Lysophosphatidic Acid, a Novel Lipid Mediator, on Cytosolic Ca2+ and Contractility in Cultured Rat Mesangial Cells, Circulation Research, vol.77, issue.5, pp.77-888, 1995.
DOI : 10.1161/01.RES.77.5.888

C. N. Inoue, Y. H. Ko, W. B. Guggino, H. G. Forster, and M. Epstein, Lysophosphatidic Acid and Platelet-Derived Growth Factor Synergistically Stimulate Growth of Cultured Rat Mesangial Cells, Experimental Biology and Medicine, vol.216, issue.3, pp.370-379, 1997.
DOI : 10.3181/00379727-216-44184

M. Goppelt-struebe, A. Hahn, D. Iwanciw, M. Rehm, and B. Banas, Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins), Molecular Pathology, vol.54, issue.3, pp.54-176, 2001.
DOI : 10.1136/mp.54.3.176

R. J. Dixon and N. J. Brunskill, Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERK, Kidney International, vol.56, issue.6, pp.2064-2075, 1999.
DOI : 10.1046/j.1523-1755.1999.00797.x

R. J. Dixon, K. Young, and N. J. Brunskill, Lysophosphatidic acid-induced calcium mobilization and proliferation in kidney proximal tubular cells, Am J Physiol, vol.276, pp.191-198, 1999.
DOI : 10.1046/j.1523-1755.1999.00797.x

URL : http://doi.org/10.1046/j.1523-1755.1999.00797.x

W. Lee-kwon, K. Kawano, J. W. Choi, J. H. Kim, and M. Donowitz, Lysophosphatidic Acid Stimulates Brush Border Na+/H+ Exchanger 3 (NHE3) Activity by Increasing Its Exocytosis by an NHE3 Kinase A Regulatory Protein-dependent Mechanism, Journal of Biological Chemistry, vol.278, issue.19, pp.16494-16501, 2003.
DOI : 10.1074/jbc.M300580200

N. Kumagai, C. N. Inoue, Y. Kondo, and K. Iinuma, Mitogenic action of lysophosphatidic acid in proximal tubular epithelial cells obtained from voided human urine, Clin Sci (Lond), pp.99-561, 2000.

M. F. Simon, D. Daviaud, J. P. Pradere, S. Gres, C. Guigne et al., Lysophosphatidic Acid Inhibits Adipocyte Differentiation via Lysophosphatidic Acid 1 Receptor-dependent Down-regulation of Peroxisome Proliferator-activated Receptor ??2, Journal of Biological Chemistry, vol.280, issue.15, pp.14656-14662, 2005.
DOI : 10.1074/jbc.M412585200

URL : https://hal.archives-ouvertes.fr/inserm-00110113

R. L. Chevalier, Obstructive nephropathy: towards biomarker discovery and gene therapy, Nature Clinical Practice Nephrology, vol.17, issue.3, pp.157-168, 2006.
DOI : 10.1038/ncpneph0098

S. Klahr and J. Morrissey, Obstructive nephropathy and renal fibrosis, American Journal of Physiology - Renal Physiology, vol.283, issue.5, pp.861-875, 2002.
DOI : 10.1152/ajprenal.00362.2001

J. S. Koh, W. Lieberthal, S. Heydrick, and J. S. Levine, Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway., Journal of Clinical Investigation, vol.102, issue.4, pp.716-727, 1998.
DOI : 10.1172/JCI1002

J. Llodra, V. Angeli, J. Liu, E. Trogan, E. A. Fisher et al., Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques, Proceedings of the National Academy of Sciences, vol.101, issue.32, pp.11779-11784, 2004.
DOI : 10.1073/pnas.0403259101

T. P. Haverty, C. J. Kelly, W. H. Hines, P. S. Amenta, M. Watanabe et al., Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis, The Journal of Cell Biology, vol.107, issue.4, pp.1359-1368, 1988.
DOI : 10.1083/jcb.107.4.1359

H. Yokoi, M. Mukoyama, T. Nagae, K. Mori, T. Suganami et al., Reduction in Connective Tissue Growth Factor by Antisense Treatment Ameliorates Renal Tubulointerstitial Fibrosis, Journal of the American Society of Nephrology, vol.15, issue.6, pp.1430-1440, 2004.
DOI : 10.1097/01.ASN.0000130565.69170.85

H. Yokoi, M. Mukoyama, A. Sugawara, K. Mori, T. Nagae et al., Role of connective tissue growth factor in fibronectin expression and tubulointerstitial fibrosis, American Journal of Physiology - Renal Physiology, vol.282, issue.5, pp.933-942, 2002.
DOI : 10.1152/ajprenal.00122.2001

K. Nagatoya, T. Moriyama, N. Kawada, M. Takeji, S. Oseto et al., Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction, Kidney International, vol.61, issue.5, pp.61-1684, 2002.
DOI : 10.1046/j.1523-1755.2002.00328.x

W. H. Moolenaar, L. A. Van-meeteren, and B. N. Giepmans, The ins and outs of lysophosphatidic acid signaling, BioEssays, vol.140, issue.8, pp.870-881, 2004.
DOI : 10.1002/bies.20081

A. Fukuzaki, J. Morrissey, and S. Klahr, Enhanced glomerular phospholipase activity in the obstructed kidney, International Urology and Nephrology, vol.258, issue.6, pp.783-790, 1995.
DOI : 10.1007/BF02552148

C. M. Lloyd, A. W. Minto, M. E. Dorf, A. Proudfoot, T. N. Wells et al., RANTES and Monocyte Chemoattractant Protein???1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis, The Journal of Experimental Medicine, vol.8, issue.7, pp.1371-1380, 1997.
DOI : 10.1056/NEJM199411103311907

M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan et al., BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury, pp.964-968, 2003.

M. M. Shull, I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold et al., Targeted disruption of the mouse transforming growth factor-??1 gene results in multifocal inflammatory disease, Nature, vol.359, issue.6397, pp.693-699, 1992.
DOI : 10.1038/359693a0